InflaRx Historical Balance Sheet
IFRX Stock | USD 2.36 0.05 2.16% |
Trend analysis of InflaRx NV balance sheet accounts such as Short and Long Term Debt Total of 1.1 M or Other Current Liab of 2.8 M provides information on InflaRx NV's total assets, liabilities, and equity, which is the actual value of InflaRx NV to its prevalent stockholders. By breaking down trends over time using InflaRx NV balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining InflaRx NV latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InflaRx NV is a good buy for the upcoming year.
InflaRx NV Inventory |
|
InflaRx |
About InflaRx Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of InflaRx NV at a specified time, usually calculated after every quarter, six months, or one year. InflaRx NV Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of InflaRx NV and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which InflaRx currently owns. An asset can also be divided into two categories, current and non-current.
InflaRx NV Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of InflaRx NV assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in InflaRx NV books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on InflaRx NV balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of InflaRx NV are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from InflaRx NV's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into InflaRx NV current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.At this time, InflaRx NV's Non Currrent Assets Other are fairly stable compared to the past year. Cash And Short Term Investments is likely to rise to about 93.4 M in 2024, whereas Total Assets are likely to drop slightly above 106.8 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Current Liabilities | 18.8M | 13.0M | 16.8M | 10.7M | Other Current Liabilities | 8.4M | 7.7M | 4.5M | 2.8M |
InflaRx NV balance sheet Correlations
Click cells to compare fundamentals
InflaRx NV Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InflaRx NV balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 121.6M | 88.2M | 125.1M | 102.4M | 120.2M | 106.8M | |
Short Long Term Debt Total | 846.0K | 559.0K | 1.4M | 1.4M | 1.1M | 1.1M | |
Other Current Liab | 1.1M | 117.7K | 8.4M | 7.7M | 4.5M | 2.8M | |
Total Current Liabilities | 14.1M | 10.1M | 18.8M | 13.0M | 16.8M | 10.7M | |
Total Stockholder Equity | 107.1M | 77.9M | 105.3M | 88.3M | 102.7M | 86.6M | |
Other Liab | 67.9K | 39.0K | 33.3K | 35.0K | 40.3K | 37.6K | |
Net Tangible Assets | 151.2M | 106.7M | 77.5M | 105.0M | 120.8M | 81.2M | |
Property Plant And Equipment Net | 1.4M | 955.0K | 1.7M | 1.6M | 1.4M | 988.9K | |
Net Debt | (32.3M) | (25.4M) | (24.8M) | (14.9M) | (11.6M) | (12.2M) | |
Retained Earnings | (134.4M) | (168.3M) | (214.0M) | (243.5M) | (286.1M) | (271.8M) | |
Accounts Payable | 12.4M | 8.3M | 1.7M | 5.0M | 12.0M | 6.4M | |
Cash | 33.1M | 26.0M | 26.2M | 16.3M | 12.8M | 12.1M | |
Non Current Assets Total | 2.6M | 1.9M | 29.5M | 5.0M | 10.7M | 6.3M | |
Non Currrent Assets Other | 452.2K | 353.5K | 336.6K | 308.1K | 283.2K | 381.2K | |
Other Assets | (2.0) | 353.5K | 336.6K | (8.9K) | (8.0K) | (7.6K) | |
Cash And Short Term Investments | 115.5M | 81.1M | 83.4M | 81.8M | 90.3M | 93.4M | |
Common Stock Total Equity | 2.9M | 3.1M | 3.1M | 3.4M | 3.9M | 2.3M | |
Common Stock Shares Outstanding | 26.0M | 27.1M | 41.6M | 44.2M | 54.9M | 33.6M | |
Short Term Investments | 82.4M | 55.2M | 57.2M | 65.5M | 77.5M | 53.6M | |
Liabilities And Stockholders Equity | 121.6M | 88.2M | 125.1M | 102.4M | 120.2M | 106.8M | |
Non Current Liabilities Total | 369.8K | 253.8K | 1.1M | 1.0M | 782.6K | 743.5K | |
Capital Lease Obligations | 845.9K | 559.0K | 1.4M | 1.4M | 1.1M | 649.5K | |
Other Current Assets | 1.3M | 3.7M | 11.0M | 14.2M | 4.0M | 4.3M | |
Other Stockholder Equity | 213.2M | 216.6M | 283.4M | 289.8M | 341.7M | 210.9M | |
Total Liab | 14.4M | 10.4M | 19.9M | 14.1M | 17.6M | 14.7M | |
Long Term Investments | 272.6K | 272.3K | 27.2M | 2.9M | 9.1M | 4.9M | |
Property Plant And Equipment Gross | 1.4M | 955.0K | 1.7M | 1.6M | 4.3M | 4.5M | |
Total Current Assets | 119.0M | 86.3M | 95.7M | 97.4M | 109.5M | 100.6M | |
Accumulated Other Comprehensive Income | 25.1M | 26.3M | 30.6M | 36.6M | 40.1M | 30.9M | |
Non Current Liabilities Other | (1.0) | 33.3K | 35.0K | 36.9K | 42.4K | 44.5K | |
Short Term Debt | 515.2K | 338.5K | 366.2K | 369.4K | 374.3K | 275.1K | |
Intangible Assets | 452.4K | 350.2K | 235.2K | 138.9K | 42.8K | 40.7K | |
Common Stock | 3.1M | 3.4M | 5.3M | 5.4M | 7.1M | 3.7M | |
Property Plant Equipment | 624.7K | 1.4M | 955.0K | 1.7M | 1.9M | 2.0M | |
Net Invested Capital | 107.1M | 77.9M | 105.3M | 88.3M | 102.6M | 85.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.